This Biotech Week, join IRBM for a half-day event that puts the toughest questions in drug discovery under the spotlight.
Through lively talks and interactive debate with leaders from biotech, academia, and venture, we’ll explore how promising companies and research organizations are advancing discovery in today’s environment, and we’ll take you inside the high-stakes go/no-go decisions that determine which programs move forward.
The event features two consecutive, science-driven sessions:
Session 1: Navigating the Drug Discovery Landscape
Short talks from leaders in biotech offering insights into how their organizations are navigating today’s complex drug discovery landscape.
Speakers:
- Paul Feldman, PhD, CSO, Aktis Oncology
- Darren Cawkill, PhD, VP, Program Leader, Apollo Therapeutics
- Carlo Toniatti, MD, PhD, CSO, IRBM
Session 2: The $50M Decision
An interactive, inside look at high-stakes go/no-go calls throughout a realistic drug discovery program — where YOU, the audience, will get to vote on the next step forward — and how scientific evidence, business priorities, and funding realities come together in the decision-making process.
Panelists:
- Nadim Shohdy, PhD, Chief Operating Officer, Deerfield Discovery and Development
- Jeff Kovacs, PhD, VP & Head of Biology, Aktis Oncology
- Pier Giuseppe Pelicci, MD, PhD, Director, IEO (European Institute of Oncology)
Moderator:
- Alessandro Carugo, PhD, Director & Head of Oncology, IRBM
The Science Talks at IRBM – Biotech Week 2025 event
has now concluded.
A sincere thank you to everyone who joined us!
We will make available some event highlights.
If you are interested, please fill out the form and you will be notified as soon as they are released.
